Legend Biotech Corp ADR (LEGN): Next-Year EPS Estimate 1357.95%
As of 2026-11-06, Legend Biotech Corp ADR (LEGN) has a next-year EPS growth estimate of 1357.95%. Featured in 3 EPS revision reports, most recently on 2026-04-23.
On 2026-10-14, analyst consensus for LEGN's next-year EPS growth shifted from 1246.72% to 1357.95% — a positive change of 111.23 percentage points. The revised estimate has been sustained across 19 subsequent trading sessions. Current-year growth is projected at 94.69%.
What's Driving This
LEGN’s rise is primarily tied to the upward revision in next-year EPS growth estimates, raised to 1,357.95% from 1,246.72% on 2026-10-14. The recent Johnson & Johnson headline about exiting three biotechs while keeping stakes in rumored acquisition targets does not clearly explain the EPS upgrade or LEGN’s
Generated 2026-11-06 from news as of 2026-11-06
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 1357.95%
- EPS growth this year
- 94.69%
- EPS next quarter (est)
- $0.00
- Last price
- $22.54
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-11-06 | 1357.95% | 94.69% | $0.00 | $22.54 |
| 2026-11-05 | 1357.95% | 94.69% | $0.00 | $22.54 |
| 2026-11-04 | 1357.95% | 94.69% | $0.00 | $22.77 |
| 2026-11-03 | 1357.95% | 94.69% | $0.00 | $21.48 |
| 2026-11-02 | 1357.95% | 94.69% | $0.00 | $21.10 |
| 2026-10-31 | 1357.95% | 94.69% | $0.00 | $21.63 |
| 2026-10-30 | 1357.95% | 94.69% | $0.00 | $21.63 |
| 2026-10-29 | 1357.95% | 94.69% | $0.00 | $22.30 |
| 2026-10-28 | 1357.95% | 94.69% | $0.00 | $22.53 |
| 2026-10-27 | 1357.95% | 94.69% | $0.00 | $21.56 |
| 2026-10-26 | 1357.95% | 94.69% | $0.00 | $20.39 |
| 2026-10-23 | 1357.95% | 94.69% | $0.00 | $19.27 |
| 2026-10-22 | 1357.95% | 94.69% | $0.00 | $18.90 |
| 2026-10-21 | 1357.95% | 94.69% | $0.00 | $18.63 |
| 2026-10-20 | 1357.95% | 94.69% | $0.00 | $19.01 |
| 2026-10-19 | 1357.95% | 94.69% | $0.00 | $18.65 |
| 2026-10-16 | 1357.95% | 94.69% | $0.00 | $18.48 |
| 2026-10-15 | 1357.95% | 94.69% | $0.00 | $19.80 |
| 2026-10-14 | 1357.95% | 94.69% | $0.00 | $19.04 |
| 2026-10-13 | 1246.72% | 94.19% | $0.00 | $17.88 |
| 2026-10-12 | 1253.81% | 94.19% | $0.00 | $17.80 |
| 2026-10-11 | 1297.01% | 94.23% | $0.00 | $18.62 |
| 2026-10-10 | 1297.01% | 94.23% | $0.00 | $18.62 |
| 2026-10-09 | 1297.01% | 94.23% | $0.00 | $18.62 |
| 2026-10-08 | 1354.51% | 94.29% | $0.00 | $18.71 |
| 2026-10-07 | 1435.94% | 94.62% | $0.00 | $19.12 |
| 2026-10-06 | 1435.94% | 94.62% | $0.00 | $18.72 |
| 2026-10-05 | 1865.95% | 95.86% | $0.00 | $18.77 |
| 2026-10-04 | 1865.95% | 95.86% | $0.00 | $18.57 |
| 2026-10-03 | 1865.95% | 95.86% | $0.00 | $18.57 |
Reports Featuring LEGN
Recent News
Screen Performance
Aggregate stats across all 2130 tickers our top-EPS-revision screen has flagged over the past 219 days.
- Median return since detection
- -3.9%
- % of tickers in the green
- 41%
- Median return on winners
- +23.3%
- Large revisions captured
- 2083
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is Legend Biotech Corp ADR's next-year EPS growth estimate?▾
As of 2026-11-06, Legend Biotech Corp ADR (LEGN) has a next-year EPS growth estimate of 1357.95%, based on analyst consensus.
When was the latest EPS estimate revision for LEGN?▾
The most recent revision occurred on 2026-10-14, when analysts adjusted the next-year EPS growth estimate from 1246.72% to 1357.95%.
What sector and industry does Legend Biotech Corp ADR belong to?▾
Legend Biotech Corp ADR operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. LEGN appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Legend Biotech Corp ADR (LEGN) appears here because it was detected by our daily top-EPS-revision-performer screen.